BioDelivery Sciences (BDSI) Misses Q4 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. CL
6. LYB
7. MRVL
8. TFII
9. SPY
10. AAPL

Go back to BioDelivery Sciences (BDSI) Misses Q4 EPS by 5c

BioDelivery Sciences Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update

March 15, 2018 4:01 PM EDT

Full-year 2017 net revenue of $62.0 million vs. $15.5 million in 2016

BELBUCA® fourth quarter 2017 net revenue of $9.4 million vs. $6.4 million in third quarter; an increase of 47%

BELBUCA prescription growth of 84% in 2017 over 2016

Preferred coverage for BELBUCA secured with Humana, the second largest Medicare insurer in the country, effective March 1

BELBUCA launched in Canada in January by commercial partner Purdue (Canada)

Conference Call Today at 4:30 PM Eastern Time

RALEIGH, N.C., March 15, 2018 (GLOBE NEWSWIRE)... More